What this means
A study plans to test saffron extract capsules in healthy adults for skin health and safety. It has not started, so no results exist yet.
Plain-English summary written by an AI model from the registry listing.
- Status
- Opening soon
- Who can join
- Ages 30–55
- Where
- Not listed
The science
- Registered title
- Clinical Study to Assess Safety, Effectiveness and In-Use Tolerability of Saffron Extract Capsules for Improving Skin Health and Reducing Signs of Aging on Healthy Adult Male and Female Subjects.
- Trial ID
- NCT07324759 ↗
- Phase
- Not applicable
- Study type
- interventional
- Conditions
- Wrinkles, Fine Lines, Hyperpigmentation, Dark Spots
- What is tested
- Standardized Saffron Extract (Crocus Sativus L) 10 mg Capsule, Placebo (capsules containing Maltodextrin, Calcium carbonate, Sunset yellow, Maize starch, Mg Stearate, Talc)
- Sponsor
- NovoBliss Research Pvt Ltd
- Ages
- 30 Years to 55 Years
- Dates
- First posted Jan 7, 2026 · updated Jan 7, 2026
Registry summary
This is a randomized, double-blind, comparative, two-arm, prospective, interventional, multi-centre clinical study to evaluate the safety, efficacy, and in-use tolerability of test products, standardized saffron extract capsules, on skin rejuvenation and age-defying benefits in healthy adult male and female subjects.
